Zdrowie i gospodarka · 23/10/2001

FDA Requests Public Comment on Proposed Fast Track Drug Development Program Information Collection

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to fast track drug development programs, as required by the Paperwork Reduction Act of 1995, and invites comments on the proposed extension of this collection for 60 days.